SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 353 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,100,264 | -21.6% | 8,491 | -33.1% | 0.23% | -25.2% |
| Q3 2022 | $1,403,000 | +47.4% | 12,689 | +45.5% | 0.30% | +17.8% |
| Q4 2018 | $952,000 | -60.1% | 8,722 | -40.9% | 0.26% | -26.8% |
| Q3 2018 | $2,385,000 | -29.8% | 14,766 | -42.5% | 0.35% | -33.8% |
| Q2 2018 | $3,396,000 | +14.7% | 25,692 | -35.7% | 0.54% | +8.5% |
| Q1 2018 | $2,962,000 | +6.6% | 39,980 | -19.9% | 0.49% | -1.0% |
| Q4 2017 | $2,778,000 | +0.1% | 49,920 | -18.4% | 0.50% | +35.0% |
| Q3 2017 | $2,774,000 | -21.0% | 61,155 | +6.9% | 0.37% | -21.8% |
| Q3 2016 | $3,512,000 | – | 57,186 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |